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Intact melanocortin signaling via the G protein-coupled receptors (GPCRs), melanocor-
tin receptor 4 (MC4R), and melanocortin receptor 3 (MC3R) is crucial for body weight 
maintenance. So far, no connection between melanocortin signaling and hypothalamic 
inflammation has been reported. Using a bimolecular fluorescence complementation 
library screen, we identified a new interaction partner for these receptors, ring finger 
protein 11 (RNF11). RNF11 participates in the constitution of the A20 complex that 
is involved in reduction of tumor necrosis factor α (TNFα)-induced NFκB signaling, an 
important pathway in hypothalamic inflammation. Mice treated with high-fat diet (HFD) 
for 3 days demonstrated a trend toward an increase in hypothalamic Rnf11 expression, 
as shown for other inflammatory markers under HFD. Furthermore, Gs-mediated signal-
ing of MC3/4R was demonstrated to be strongly reduced to 20–40% by co-expression 
of RNF11 despite unchanged total receptor expression. Cell surface expression was 
not affected for MC3R but resulted in a significant reduction of MC4R to 61% by co-ex-
pression with RNF11. Mechanisms linking HFD, inflammation, and metabolism remain 
partially understood. In this study, a new axis between signaling of specific body weight 
regulating GPCRs and factors involved in hypothalamic inflammation is suggested.
Keywords: g protein coupled receptor, protein complementation assay, protein network, weight regulation, 
inflammation
inTrODUcTiOn
Obesity and its associated comorbidities, such as type 2 diabetes or cardiovascular diseases, rep-
resent critical global health issues. Increasing caloric intake and/or reduced energy expenditure 
leads to excessive energy storage resulting in adipose accumulation, coupled to chronic low-grade 
inflammation (1–3) and weight gain. Numerous high-fat diet (HFD) analyses have revealed that 
inflammation not only occurs in peripheral tissue but also results in a non-classical form of 
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inflammation in the hypothalamus, particularly in the arcuate 
(ARC) and paraventricular nucleus (PVN) (1, 3). Hypothalamic 
inflammatory changes have been detected within a short period 
of 3 days HFD (1, 4). In addition to microglia invasion, gene 
expression analyses revealed increased hypothalamic levels of 
inflammatory markers such as interleukin 6 (Il6), tumor necrosis 
factor α (Tnfα), suppressor of cytokine signaling 3 (Socs3), and 
inhibitor of nuclear factor kappa-B kinase subunit beta or epsilon 
(Ikbkb/Ikbke) (1, 4). The known functions of leptin and insulin 
receptors have been reported to be affected by HFD-induced 
hypothalamic inflammation. Hypothalamic leptin resistance has 
already been shown to develop very early in the first 1–3 days 
of HFD (5). Upregulation of Socs3 and various inflammatory 
pathways are presumed to be contributors to leptin insensitiv-
ity (5, 6). Continuous HFD, inflammation, and manifesting 
leptin resistance lead to peripheral and hypothalamic insulin 
insensitivity (7).
Aside from leptin and insulin receptors, the G protein-coupled 
receptors (GPCR) and melanocortin 3 and 4 receptor (MC3/4R) 
are important regulators of body weight and energy consumption, 
as part of the hypothalamic leptin–melanocortin pathway (8).
Regarding the leptin–melanocortin axis, PVN expressed 
MC4R is the most prominent MCR in weight regulation (9, 10). 
MC4R knockout or loss-of-function variants in humans result 
in hyperphagia and early onset obesity (11–13). Furthermore, 
MC3R is expressed in the ARC on POMC neurons and agouti-
related peptide (AgRP) neurons. MC3R knockout mice develop 
increased fat mass, hyperleptinemia, or hyperinsulinemia (14, 15). 
MC3/4R activity is primarily controlled by MSH, processed from 
POMC in anorexigenic POMC neurons and by AgRP, which is 
expressed in orexigenic AgRP neurons (10, 16, 17).
To further investigate the role of MC3R and MC4R, we applied 
a screening system that identified ring finger protein 11 (RNF11) 
as a potential hypothalamic melanocortin receptor interaction 
partner. RNF11 is a highly conserved E3 ligase, with different 
physiological functions (18) and operates as a compound of the 
A20 complex. The A20 complex is an ubiquitin-editing enzyme 
that plays a critical role in the termination of TNFα-induced 
canonical NFκB signaling pathway (19, 20).
In the present study, we tried to confirm the MCR/RNF11 
interaction and analyzed the impact of RNF11 on MCR function 
in particular with regard to the early developed hypothalamic 
inflammatory changes during HFD.
MaTerials anD MeThODs
Vector construction
Mc3r, Mc4r, Ghsr, Gpr83, and Rnf11 were amplified from murine 
hypothalamic cDNA. MC3R was amplified from human genomic 
DNA and GHSR from human cDNA (UMR cDNA Resource 
Center, Rolla, MO, USA). The pcDps [NHA-Chrm3], origin of all 
rCHRM3 (rat cholinergic receptor, muscarinic 3) constructs, was 
kindly provided by Torsten Schöneberg (University of Leipzig, 
Germany). The origin of YFP-fragment constructs was pcDNA3 
(MCFD2-YFP1/YFP2) plasmids, which were kindly provided by 
Hans-Peter Hauri (University of Basel, Switzerland) (21). For 
direct interaction analysis of two known proteins in YFP-BiFc, 
MCFD2 was replaced by the here relevant full-length genes 
(without stop codons). The pECFP-N1 (Mc3r-YFP1) (kanamycin 
resistance), required for the YFP-BiFc screening, was created 
by replacement of ECFP with Mc3r-YFP1. pECFP-N1 was pur-
chased from Invitrogen (Darmstadt, Germany). The normalized 
murine hypothalamic cDNA library for screening was produced 
from wild-type hypothalami and inserted into pcDNA3-YFP2 
(ampicillin resistance) by Eurofins MWG Operon (Ebersberg, 
Germany). The hemagglutinin tag was inserted at the amino 
terminus (NHA) and the FLAG tag at the carboxyl terminus. 
Reporter constructs pGL4.30 (luc2P/NFAT-RE/Hygro) and 
pGL4.33 (luc2P/SRE/Hygro) were purchased from Promega 
(Mannheim, Germany). The pGL4.34 (luc2P/NFκB-RE/Hygro) 
for detection of NFκB-activity was kindly provided by Vera 
Knaeuper (Cardiff University, Cardiff, United Kingdom).
cell culture and Transfection
HEK293 and COS-7 cells were cultured as described elsewhere 
(22). For bimolecular fluorescence complementation (BiFc) 
approaches, HEK293 cells were seeded in 6-cm dishes (8.5 × 105 
cells/dish) and transfected with 1.9 μg DNA: 5.9 μl Metafectene™/
dish (Biontex, Martinsried, Germany). For cAMP accumulation 
and cell viability tests, COS-7 cells were seeded into 96-well plates 
(0.9 × 104 cells/well). For measurement of NFAT, SRE and NFκB 
activity via reporter gene assays, HEK293 cells were seeded in 
96-well plates (1.5  ×  104 cells/well) coated with poly-l-lysine 
(Biochrom, Berlin, Germany). Cell viability of HEK293 cells 
was also examined in 96-well plates. Transfection in 96-well 
plates was performed with 41.7 ng plasmid DNA/well and 0.5 μl 
Metafectene™/well. For reporter gene assays, equal amounts of 
the appropriate reporter construct containing the firefly lucif-
erase gene was co-transfected. For cell surface expression studies, 
COS-7 cells were seeded into 48-well plates (3.8 × 105 cells/well) 
and transfected with 167  ng DNA and 1 μl Metafectene™/well 
(22). Total expression studies via sandwich ELISA were per-
formed with COS-7 cells seeded in 6-cm dishes (6.5 × 105 cells/
dish) and transfected with 3 μg DNA and 8 μl Metafectene™/dish. 
All transfections were performed 1 day after seeding.
Cell lines that were chosen were well established in respective 
assays. YFP-BiFc analysis was performed in HEK293 cells due to 
optimal transfection results in combination with well detectable 
fluorescence signals. In addition to HEK293 cells, more robust 
COS-7 cells were used for wash intensive ELISA systems in 
expression studies. In regards to both cell lines, functional recep-
tor studies were performed in HEK293 and COS-7 cells.
interaction Partner screening and 
association studies via YFP-Based 
Bimolecular Fluorescence 
complementation assay
For screening, pECFP-N1 (Mc3r-YFP1) and pcDNA3 (hypotha-
lamic cDNA library-YFP2) were co-transfected. Two days after 
transfection, cells were harvested and analyzed for fluorescence 
using AriaII SORP and the FACSDiva v6 program (Becton 
Dickinson, Heidelberg, Germany) at the Berlin-Brandenburg 
Center for Regenerative Therapies (BCRT, Charité Berlin). The 
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cell sorter was adjusted with an interaction positive [MC3R-
YFP1  +  GHSR-YFP2 (23)] and negative control [rCHRM3-
YFP1 +  GHSR-YFP2 (24)]. Plasmid DNA from YFP-positive 
cells was purified using QIAmp DNA Blood Mini Kit (Qiagen, 
Hilden, Germany) and introduced into E. coli cells. Clones car-
rying library constructs were selected via antibiotic resistance, 
analyzed by sequencing, and evaluated via NCBI-BLAST.
Direct interaction or association between two defined proteins 
was analyzed in YFP-BiFc experiments using the full length genes 
as previously described (24). YFP-fluorescent cells were measured 
using the FACS Canto II at the BCRT and were analyzed with 
FlowJo 8.8.6 (Tree Star Inc., Ashland, OR, USA).
Measurement of signaling Pathways
Signaling pathways were analyzed 48  h after transfection. 
Intracellular cAMP accumulation for the determination of 
Gs activation was analyzed using the AlphaLISA technology 
(PerkinElmer, Rodgau, Germany). Human α-MSH was purchased 
from Sigma-Aldrich (Taufkirchen, Germany). Stimulation was 
performed for 45  min. Cell lysis (50  μl/well lysis buffer) and 
cAMP measurement were conducted as described elsewhere (22) 
according to the manufacturer’s protocol (PerkinElmer).
NFAT, SRE, and NFκB activity were determined in luciferase 
reporter gene assays. Stimulations with α-MSH, TNFα, and 
Ghrelin (Sigma-Aldrich) were performed for 6 h to allow appro-
priate reporter expression and according to the manufacturer’s 
instructions (Promega). Subsequently, cell lysis was performed 
with 50 μl/well of 1× Passive Lysis Buffer (Promega). Pathway 
activities were determined by luciferase activity according to the 
manufacturer’s protocol (Promega).
cell surface and Total expression studies
Cell surface and total expression studies were performed in 
COS-7 cells 48  h after transfection using ELISA systems as 
previously described (22, 24). To investigate cell surface expres-
sion, HA-tagged receptors were required. For detection of the 
HA-tag, cells were washed, fixed with paraformaldehyde, and 
probed with a biotin-labeled anti-HA antibody (Roche Applied 
Science, Mannheim, Germany). Bound biotin anti-HA antibody 
was detected by peroxidase-labeled streptavidin (BioLegend, 
London, UK) in a substrate/chromogen reaction as previously 
described (25).
Total expression was measured using HA and FLAG double-
tagged receptors. Cells were solubilized at 4°C [10 mM Tris/HCl, 
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 1% sodium 
deoxycholat, 1% NP-40 and 0.2 mM PMSF (22)]. Lysates were 
incubated in anti-FLAG antibody (Sigma-Aldrich)-coated 
96-well plates for 2 h. The HA epitope was detected as specified 
above. Total protein concentration of lysates was measured 
using a bicinchoninic acid (BCA)-based protein assay (Thermo 
Scientific, Bonn, Germany).
cell Viability Tests
Cell viability was measured using the CellTiter 96® Aqueous One 
Solution Cell Proliferation Assay (Promega) according to the 
manufacturer’s instructions (10 μl 96® solution/50 μl medium). 
Viability tests were performed 48 h after transfection.
animals and cDna synthesis
All procedures were approved by the Animal Care and Use 
Committee at the State Ministry of Rural Development, 
Environment and Consumer Protection of Brandenburg, 
Germany, in accordance with the German Animal Welfare Act 
(V3-2347-04-2013).
Hypothalami from ad  libitum standard chow (S, 3.3  kcal% 
fat; Ssniff GmbH, Soest, Germany) and high-fat (HF, 60 kcal% 
fat; Research Diets Inc., New Brunswick, NJ, USA) diet-fed male 
mice (C57BL/6J) were sampled at an age of 6–6.5 weeks. HFD 
was administered for 3  days before salvation. RNA extractions 
were performed using 1  ml TRIzol® reagent (Sigma-Aldrich) 
per hypothalamus according to the manufacturer’s instructions. 
Following DNaseI (New England Biolabs, Frankfurt am Main, 
Germany) digestion and before reverse transcription, the second-
ary structure of RNA was minimized by incubation at 60°C for 
10 min. Synthesis of cDNA was performed using 400 ng RNA 
with 0.5 mM dNTP-Mix (Qiagen), 25 ng/μl Oligo(dT)15-Primer, 
and M-MLV Reverse Transcriptase under use of RNasin® Plus 
RNase Inhibitor (Promega).
Quantitative real-time Pcr
Quantitative real-time PCR was performed using the SsoFast™ 
EvaGreen® Supermix (Bio-Rad, Hercules, CA, USA). Primers 
specific for six reference genes were analyzed for the compared 
murine samples: ribosomal protein, large, P0 (Rplp0), 18S riboso-
mal RNA (Rn18S), beta-actin (Actb), polymerase (RNA) II (DNA 
directed) polypeptide A (Polr2a), TATA box binding protein (Tbp), 
and hypoxanthine guanine phosphoribosyl transferase (Hprt). 
The reference gene Actb was chosen in this experiment due to 
its minimal variation across experimental groups (analyzed by 
geNorm of the qBase software, Zulte, Belgium). Quantitative PCR 
data were analyzed using the comparative Ct method. Ct is the 
quantification cycle number at which the light outcome of qPCR 
is first recorded above the background signals. The difference of 
the average Ct value for the gene of interest and the average Ct 
value for the reference gene represents ΔCt. To receive the relative 
quantitation of gene expression, the arithmetic formula 2−ΔCt was 
used (Applied Biosystems’ User Bulletin 2, Foster City, CA, USA).
statistical analyses
All data were checked for normal distribution and expressed as 
mean ±  or +  SEM. Statistical analyses were performed using 
the statistical tools implemented in Graph Pad Prism, version 6 
(GraphPad Software, San Diego, CA, USA).
resUlTs
rnF11 as screening hit for a Potential 
Mc3r interaction or association
In the initial screening via YFP-based bimolecular fluores-
cence complementation (YFP-BiFc), we investigated potential 
new murine hypothalamic MC3R interaction partners. The 
MC3R was chosen due to its known and particularly well-
characterized capability to interact in a functional relevant 
manner with several other proteins such as receptors and 
FigUre 1 | rnF11 interacts with Mc3/4r. Interaction studies via 
YFP-based protein complementation assay (YFP-BiFc). Positive control, 
human MC3R/GHSR heterodimer (23); negative control, GHSR/non-
interacting protein (NIP, rCHRM3) co-expression (24). No YFP1/YFP2 tags 
are displayed due to the combination of values from vice versa assays 
(e.g., first gray column: values from RNF11-YFP1 + MC3R-YFP2 and values 
from RNF11-YFP2 + MC3R-YFP1 experiments). Fifty thousand cells were 
analyzed on fluorescence per sample and experiment. Data were assessed 
from a minimum of three independent experiments, each performed in 
triplicates, and calculated to the control. Values represent the mean + SEM. 
Significance to negative control ***p ≤ 0.001 (one-way ANOVA, Dunnett’s 
test).
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accessory proteins (23, 26, 27). The initial sorting process was 
stopped after 30 min. During this time, 3,900 YFP fluorescent 
cells were collected. Subsequent selection for library constructs 
resulted in 239 bacterial clones. Sequence analysis, in which 
false positive hits were sorted out (e.g., cDNA fragment not 
in frame with YFP fragment, cDNA fragment consisting of 
non-coding DNA region), revealed 16 potential hypothalamic 
interaction partners for the murine MC3R. The detected 
potential interaction partners were proteins that are typically 
found in multiple protein complexes or involved in traffick-
ing processes, cell metabolism, protein degradation, cell–cell 
communication, and cellular nutrient sensing (Table S1 in 
Supplementary Material). In the present study, we focused on 
the interplay with RNF11. RNF11 plays a crucial role in reduc-
ing NFκB signaling and, therefore, in the counterregulation 
of inflammation. RNF11 represents an important component 
of the NFκB-inhibiting A20 complex (19, 20). NFκB, which is 
activated by TNFα, has been shown to result in an upregula-
tion of A20 expression and in a higher interactivity of RNF11, 
assembling the A20 complex and protecting cells from constant 
NFκB signaling (20). Known hypothalamic expression, present 
structural protein-binding motifs (28, 29), and previously pub-
lished interaction findings (19, 20) give rise to the possibility 
that RNF11 represents a potential and important interaction 
partner for neuronal GPCRs of weight regulation.
In addition to MC3R, we also concentrated on the most 
important GPCR in hypothalamic weight regulation, the MC4R. 
MC3R and MC4R share a high sequence similarity. Therefore, 
further analyses focused on both melanocortin receptors.
rnF11 interacts with Mc3r and Mc4r
To confirm MC3R/RNF11 interaction and further examine 
RNF11/MC4R interplay, YFP-BiFc studies with full-length genes 
were performed (Figure 1). The co-expression of GHSR and a 
non-interactive protein (NIP) represented by the rat cholinergic 
receptor, muscarinic 3 [rCHRM3 (24), Figure  1, first white 
column] served as interaction negative and the MC3R/GHSR 
heterodimer as interaction positive controls for GPCRs [(23), 
Figure  1, black column]. Furthermore, previous studies of 
YFP-BiFc have shown that GPCRs do not randomly aggregate 
with any other co-expressed and overexpressed proteins in this 
assay system (24). Interaction negative controls for MC3/4R 
(co-expression with NIP, rCHRM3) have been previously shown 
(24, 30), and similar results were reported as the negative control 
in the present study. To establish RNF11 interaction controls, 
homodimerization of the soluble protein was demonstrated 
(Figure 1, dark gray column) in addition to non-interaction with 
rCHRM3 (Figure 1, third column). Interaction of RNF11 with 
MC3/4R was confirmed via full-length YFP-BiFc (Figure 1, light 
gray columns).
In BiFc studies, fluorescence analysis does not provide quanti-
tative information of intracellular interaction as it is usually irre-
versible. Equal expression of transfected YFP1 and YFP2 tagged 
proteins was assumed but not verified. Furthermore, due to the 
detection of interactions within a distance of several nanometers 
by BiFc, interaction partners that act imbedded in complexes and 
direct protein–protein interactions can be identified using BiFc. 
In a sandwich ELISA system including destructive cell lysis and 
several washing steps, RNF11 interactions were not detected. 
Therefore, we cannot exclude that further cellular proteins are 
involved in, or even mediate, the MC3R and MC4R interaction 
with RNF11. For simplification purposes, the MCR/RNF11 
interplay will be termed here as interaction.
Mc3/4r signaling capacity 
is inhibited by rnF11
Alpha-MSH-induced cAMP accumulation (Gs signaling) 
through MC3R (Figure 2A) and MC4R activation (Figure 2B) in 
co-expression with the NIP [rCHRM3 (24, 30)] resulted in typical 
concentration response curves with a stimulation maxima of 160 
to 200-fold cAMP accumulation compared with the basal empty 
vector. EC50 values of MCR/NIP co-expressions were measured 
at 5–8 nM α-MSH (Figures 2A,B). Co-expression with RNF11 
led to a reduction to 44% of MC3R signaling and 19% of MC4R 
signaling in Gs in response to 100 nM α-MSH without an effect 
on the EC50 value (Figures 2A,B). In addition to the main Gs 
pathway, ligand-induced activation of MC4R has been reported 
to modify the activity of extracellular regulated kinases [(31, 32) 
ERK 1/2 signaling], AMP-activated kinases (33), c-jun kinases 
(34), protein kinases C (35), and phosphatidylinositol-3-kinases 
[(31, 36) IP3 formation]. To investigate whether RNF11 specifi-
cally inhibits Gs signaling of MCRs, two additional pathways were 
FigUre 2 | rnF11 inhibits Mc3/4r signaling. Functional studies of MC3R and MC4R in cAMP accumulation (a,B), NFAT (c), and SRE-controlled luciferase 
activity (D). Concentration response curves to α-MSH (a–c). MC3/4R co-expressions with a non-interactive protein [NIP, rCHRM3 (30); black filled triangles] are 
opposed to the GPCR/RNF11 interplay (unfilled triangles). In (D) MC4R, co-expression with NIP (first column pair) is opposed to the MC4R/RNF11 interaction 
(second column pair) in the absence (basal) or presence of α-MSH. For assay control, single gene or plasmid transfections of the empty vector, RNF11, and NIP 
were performed. To ensure equal amounts of plasmid DNA in each transfection, single gene approaches were filled with empty vector. Data were assessed from a 
minimum of three independent experiments, each performed in triplicates. Values represent mean ± SEM. Significance was determined as stimulated MCRs + NIP 
to stimulated MCRs + RNF11. ***p ≤ 0.001 (two-way ANOVA for factor RNF11 and α-MSH, Sidak test due to extreme low SDs in co-expressions with RNF11 
compared with MCRs/NIP).
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analyzed (Figures 2C,D). The activity of the transcription factor 
NFAT and therefore NFAT-driven luciferase activity (Figure 2C) 
occurs downstream of IP3 formation. SRE-driven luciferase 
activity (Figure  2D) suggests an upstream MAPK/ERK 1/2 
activity. The murine MC4R in co-expression with NIP showed 
a 3.1-fold basal NFAT luciferase activity compared with the 
empty vector control (Figure 2C). Furthermore, stimulation with 
α-MSH also resulted in a distinct concentration response curve 
with a maximum 8.6-fold of NFAT luciferase activity compared 
with the basal empty vector with an EC50 value of 70 nM α-MSH 
(Figure 2C). Co-expression of RNF11 resulted in a complete loss 
of MC4R-mediated NFAT-driven luciferase activity (Figure 2C). 
In the SRE pathway (Figure 2D), no basal activity of MC4R/NIP 
co-expression was detected. Stimulation with 1000 nM α-MSH 
led to a slight 2.2-fold increase in SRE luciferase activity compared 
with the basal empty vector, supporting previous data that ERK 
1/2 mainly results from Gq/11 (IP3 formation) (31) (Figure 2D). 
Consistently, also for SRE signaling, RNF11 co-expression dimin-
ished MC4R-mediated signaling in total as reported for NFAT 
activity (Figures 2C,D). For the murine MC3R, neither basal nor 
α-MSH stimulated NFAT or SRE luciferase activity was detected 
(Figures 2C,D). The expression of the empty vector, RNF11 and 
NIP (rCHRM3) alone (served as controls), did not show basal 
activity or stimulation by α-MSH in the investigated signaling 
pathways (Figure 2).
Mc3/4r expression Profiles are 
Differently Modulated by rnF11
Cell surface and total expression studies were performed 
(Figures  3A,B). Using this approach, we aimed to investigate 
whether the observed functional influence on MC3/4R in the 
presence of RNF11 (Figure  2) was due to aberrant receptor 
expression. Co-transfection with NIP (Figures  3A,B, white 
columns) was compared with MC3R/RNF11 or MC4R/RNF11 
co-transfections (Figures  3A,B, black columns). Cell surface 
expression of MC3R was not significantly reduced by RNF11 
(Figure  3A). However, the cell surface presence of MC4R was 
FigUre 4 | cell viability is not influenced by rnF11 expression. Cell 
viability during MC3/4R and NIP expression (black and gray columns) was 
compared with MC3/4R and RNF11 expression (striped columns) in the used 
cell systems. Data were assessed from a minimum of three independent 
experiments, each performed in triplicates and calculated to 100% control. 
Values represent mean + SEM.
FigUre 3 | expression of Mc3/4r in the presence of rnF11 is differentially influenced. (a) Cell surface expression and (B) total expression of MC3/4R was 
analyzed in ELISA systems. The negative control in both expression studies was untagged rCHRM3 (NIP). Positive controls were NHA-rCHRM3 [NHA-NIP (a)] and 
NHA-rCHRM3-FLAG [NHA-NIP-Flag (B)]. MC3/4R co-expression with NIP (white columns) is opposed to the GPCR/RNF11 interplay (black columns). In cell surface 
expression studies, GPCRs were detected via the N-terminal HA. In total expression analysis, the HA- and Flag-double tagged receptor was used. Data were 
assessed from a minimum of three independent experiments, each performed in triplicates and calculated to 100% of the positive control. Values represent 
mean + SEM. Significance was determined as NHA-MC4R + NIP compared to NHA-MC4R + RNF11. ***p ≤ 0.001 (unpaired t-test, two tailed).
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significantly reduced to 61% by co-expression with RNF11 
(Figure 3A). Total receptor expression of both analyzed MCRs 
was not modified by co-expression with RNF11 (Figure 3B).
To analyze whether the decrease of GPCR expression and 
function in the presence of RNF11 is due to increased cell death, 
cell viability was investigated in HEK293 and COS-7 cells, cor-
responding to interaction, cAMP accumulation, reporter gene 
assays, or expression studies. As depicted in Figure 4, cell viability 
was not affected by RNF11 expression.
rnF11 has a greater impact on nFκB 
signaling reduction than α-Msh
In addition to analysis of MC4R signaling and expression in 
interaction with RNF11, the influence of MC4R on RNF11 
controlled action was also examined. Therefore, NFκB signaling 
was investigated by measuring NFκB-driven luciferase activity 
(Figure 5). NFκB luciferase activity was monitored in the absence 
(white columns) and presence (black columns) of 100 nM α-MSH 
(Figure 5) and without (Figure 5A) or with (Figure 5B) addi-
tional NFκB stimulation by TNFα. The first three column pairs 
of empty vector, NIP (rCHRM3), and RNF11 represent controls 
(Figure 5).
Data demonstrated clearly the reported NFκB inhibiting effect 
of RNF11 expressed alone (19, 20) compared with the empty 
vector alone, basal (Figure 5A), as well as under the 0.1 ng/ml 
TNFα-stimulated condition (Figure  5B). Furthermore, basal 
NFκB signaling (Figure 5A) was slightly yet significant reduced 
by MC3R and marginally enhanced by MC4R (MC3/4R in co-
expression with NIP compared with NIP alone). Although alpha-
MSH had no additional decreasing effect on the basal NFκB 
state, RNF11 also inhibited NFκB signaling in co-expression of 
MC3/4R almost completely (Figure 5A). Upon TNFα stimula-
tion (Figure 5B), the reported NFκB inhibiting effect of α-MSH 
on melanocortin receptors [(37) MC3/4R co-expressed with 
NIP] was observed. A NFκB reduction of approximately 39% 
was documented (Figure 5B). However, RNF11 expression alone 
and in combination with MC3/4R also resulted in the TNFα-
stimulated background to a stronger NFκB abatement than 
MSH. In all cases, NFκB signaling was reduced to approximately 
twofold over the basal empty vector by RNF11 (Figure 5B, reduc-
tion of 50–70%). Interestingly, for MC3R/RNF11 co-expression, 
a slight synergistic effect of NFκB inhibition by RNF11 and 
FigUre 5 | rnF11 has stronger impact on decreasing nFκB signaling than stimulated Mc3/4r. NFκB was measured using a luciferase reporter gene 
assay. In (a), basal NFκB (white columns) is compared with NFκB activity during α-MSH stimulation (black columns). In (B), cellular NFκB activity was stimulated 
with 0.1 ng/ml TNFα. In comparison, NFκB signaling in absence (white columns) and presence of α-MSH (black columns). MC3R or MC4R in co-expression with the 
non-interactive protein [NIP, rCHRM3 (30)] is opposed to MC3/4R interactions with RNF11. The first three column pairs [empty vector (e.v.), e.v. + NIP, and 
e.v. + RNF11] served as controls. Data were assessed from a minimum of three independent experiments, each performed in triplicates, and calculated fold over 
the basal empty vector. Values represent mean + SEM. Significance determined by one-way ANOVA and Dunnett’s test: basal e.v. compared with e.v. + RNF11 
(a,B); basal e.v. + NIP compared with basal MC3/4R + NIP [(a), blue statistic]; basal MC3/4R + NIP to MC3/4R + RNF11 (a,B); Significance determined by 
unpaired t-test, two-tailed: α-MSH effect on MC3/4R + NIP (B); α-MSH effect on MC3R + RNF11 (B). *p ≤ 0.05; ***p ≤ 0.001.
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α-MSH was observed, which indicates that basal NFκB signaling 
of MC3R + RNF11 is decreased compared with MC3R + NIP. A 
further decreasing effect in NFκB is obtained by α-MSH stimula-
tion in MC3R + RNF11 co-expression (Figure 5B).
rnF11 expression Trends toward 
an increase after 3 Days of hFD
The present data implies that RNF11 may play a role in the 
inhibition of MCR function during inflammation. Therefore, 
we analyzed whether hypothalamic NFκB inhibiting protein 
RNF11, as part of the A20 complex, is upregulated after 
3 days of HFD, comparable to NFκB increasing inflammatory 
factors  (1). As various genes are altered in expression after a 
short-term period of nutritional change (38), expression varia-
tion of six housekeeping genes were analyzed among standard 
diet and HFD-fed animals (see Materials and Methods). Only 
beta-actin was observed to be not affected by 3-day HFD and 
was used as reference gene in quantitative expression studies. 
Quantitative real-time PCR demonstrated Rnf11 expres-
sion  in  HFD-treated animals to be threefold higher than in 
mice that were fed a standard diet, although this was not 
significant (Figure 6).
Future studies should focus on whether methods other 
than BiFc can be used to analyze RNF11/MCR interaction. 
As Sandwich ELISA approaches failed to detect this interaction 
FigUre 6 | relative hypothalamic Rnf11 expression trends toward 
an increase following 3 days of hFD. Each group comprised of eight 
animals. qPCR of SD and HFD cDNA samples was performed in the 
same reaction plate. Gene expression of animals was analyzed in 
duplicates. All symbols display the mean of duplicates for one animal 
(detailed data can be found in Table S2 in Supplementary Material). 
For each diet group, the mean ± SEM between the animals is depicted. 
Scale of Y-axis represents Log2. Reference gene, beta-actin (Actb); 
SD, standard diet; HFD, high-fat diet.
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in the present study, we speculate that other proteins mediate 
the functional relevant RNF11/MCR interaction. Therefore, 
mass spectrometry may be applied whereby whole protein 
complexes are extracted in an initial step. In an additional step, 
RNF11 and MC3R or MC4R may be detected by tag-specific 
antibodies. Furthermore, more physiological cell lines such 
as hypothalamic cells are preferable for in  vitro studies. In 
the present study, the hypothalamic neuronal cell lines N41, 
N39, and GT1-7 were analyzed; however, we were unable to 
obtain consistent results due to poor transfection efficiency 
or expression level. Still, in the conducted in  vitro studies, 
RNF11 and MC3/4R are comparably overexpressed. Further 
studies have to reveal the physiological in  vivo relevance of 
the results.
DiscUssiOn
rnF11 influences Mc3/4r activity 
via Different Mechanisms
Functional characterization of MC3/4R revealed reduced 
signaling of these GPCRs due to co-expression with RNF11 
(Figure 2). Furthermore, signaling inhibition was not restricted 
to the main MCR cAMP accumulation pathway, but was also 
constrained to the other analyzed pathways. Therefore, RNF11 
appears to be a universal signaling blocking factor on MCRs. 
Further expression studies demonstrated that the RNF11 
effect on MC3/4R is most likely generated by two different 
mechanisms.
  (I) RNF11 can inhibit cell surface expression of a certain GPCR, 
as demonstrated in this study for MC4R, contributing to 
limited signaling capacity. Binding partners of RNF11 
that have been identified so far suggest that RNF11 is 
likely to be involved in numerous signaling and trafficking 
processes (39). For example, RNF11 directly interacts with 
proteins of the ubiquitination machinery (ITCH, NEDD4, 
and UBC13) and with proteins mediating transport 
processes [e.g., GGA family of clathrin adaptors (40)]. 
RNF11 controls ubiquitination and thereby the function 
of GGA proteins, which have been shown to be involved 
in GPCR cell surface transport through direct interaction 
(41). Consistently, we demonstrated the ability of RNF11 
to reduce MC4R cell surface expression, without changing 
total expression levels, which may be due to internalization 
or retaining of receptors in the endoplasmic reticulum and 
Golgi (Figures 3A,B).
(II) Analyses of the MC3R, which reside at the cell surface after 
RNF11 co-expression (Figure  3A), lead to the hypothesis 
that the association of RNF11 or RNF11-related protein 
complexes may inhibit GPCR activity by interfering with 
G protein coupling or G protein subunit release during 
activation.
These facts indicate specific actions of RNF11 on different 
GPCRs, resulting in the reduction of signaling capability. Several 
recognition sites on GPCRs, presented in different stages of 
receptor maturation, may determine favored RNF11 actions.
In addition to the RNF11 effect on MC3/4R function observed 
here, we also tested the impact of RNF11 on other hypothalamic 
GPCRs (Figure S1 in Supplementary Material). An interaction of 
RNF11 with the growth hormone secretagogues receptor (GHSR) 
and the G protein-coupled receptor 83 (GPR83) could be shown 
in addition to a signaling inhibition for both GPCRs through 
RNF11 co-expression. These data indicate a very consistent 
general action of RNF11 on GPCR function.
rnF11 Function on hypothalamic 
Melanocortin receptors and 
its Potential role in inflammation
Chronic non-regulated inflammation is observed in the 
pathogenesis of obesity, diabetes, arteriosclerosis, Alzheimer’s 
disease, and gout. Previously, numerous different factors such 
as acetylcholine (42), adenosine (43), or peptides, such as 
melanocortins (44, 45), have been identified to play a role in 
inflammation regulation. The targets of these factors are primar-
ily GPCRs. For the first time, the present study indicates that 
RNF11 (as part of the A20 complex) represents a further factor 
that interacts with GPCRs. We speculate this interaction may 
be relevant in hypothalamic inflammation. NFκB, activated by 
TNFα, has been shown to lead to upregulation of A20 expression 
and to a higher interactivity of RNF11 for the assembly of the 
A20 complex, protecting the cell from constant NFκB signaling 
(20) in an auto-regulatory manner (Figure  7). By identifying 
RNF11 as an interaction partner of MC3/4R, we hypothesize 
that RNF11 potentially links hypothalamic inflammation to 
MC3/4R signaling, a characteristic that has so far been attrib-
uted to leptin and insulin receptors. So far, Rnf11 knockout 
FigUre 7 | hypothesis of how Mc4r/rnF11 interplay may result in early development of leptin resistance during high-fat diet. Under healthy 
conditions (left side), leptin, which is produced in adipocytes, acts on its receptor, which is (LEPR) located on anorexigenic pro-opiomelanocortin (POMC) neurons. 
POMC is processed to melanocyte-stimulating hormones (MSH), which activate the weight controlling MC4R in its signaling pathways. NFκB signaling based on 
tumor necrosis factor α (TNFα) acting on TNFR (TNF receptors) is also found on neurons. For both, POMC and NFκB production negative feedback loops exist. 
STAT signaling of LEPR leads to SOCS3 expression and decreased LEPR signaling. TNFα/NFκB results in A20 complex formation and decreased NFκB signaling. 
RNF11 is part of the A20 complex. Hypothalamic inflammation and leptin resistance characterized by elevated TNFα (and subsequently A20) and SOCS3 have been 
reported (1, 4, 46) after 3 days of high-fat diet (HFD, right side). Furthermore, RNF11 is upregulated (Figure 6) contributing to leptin resistance and obesity by direct 
inhibition of MC4R signaling (Figure 2). Ncl, nucleus.
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animals are not existent, probably due to lethality by the loss of 
the multifunctional protein.
altered hypothalamic rnF11 expression 
during the First Day of hFD May 
contribute to leptin resistance and 
Obesity Manifestation
Obesity and a HFD, even after 3 days (1), are associated with 
systemic low-grade inflammation and leptin resistance on the 
molecular signaling level. Circulating inflammatory cytokines 
such as TNFα, free fatty acids, and immune cells reach brain 
structures particularly at the hypothalamic level to provoke 
local inflammation [(47, 48), Figure 7]. Located at the third ven-
tricle, and therefore exhibiting areas in which the blood–brain 
barrier is loosened, the hypothalamus, in particular the ARC, 
can be effectively reached by peripheral messengers. Peripheral 
inflammatory markers have been shown to activate microglia 
cells that produce local inflammatory cytokines such as TNFα, 
in turn promoting a secondary hypothalamic inflammation 
process (3, 49). Hypothalamic inflammation, characterized by 
elevated TNFα or microglia activity, has been documented after 
a short-term HFD (1).
One prominent inflammatory pathway activated by TNFα is 
NFκB. NFκB activity can be found on neurons and microglia 
and is clearly associated with obesity [(50, 51), Figure  7]. 
Activation of NFκB in microglia has been shown to lead to 
the degradation of, for example, dopaminergic neurons (52). 
Hypothalamic RNF11 appears to be upregulated in combination 
with A20 (Figure  7) to immediately counteract HFD-induced 
NFκB (Figure 6) and to provide protection particular to neurons. 
However, we hypothesize that higher RNF11 expression and 
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activity increases the probability of MCR/RNF11 interaction, 
leading to desensitization of these GPCRs within 3  days of 
HFD (Figure  7). A decrease in the function of MC3R and 
particularly MC4R strongly contributes to the development of 
leptin resistance and obesity manifestation [(11, 13), Figure 7]. 
Moreover, the very early loss of MC4R function leads to increased 
food and caloric intake (11). Thus, RNF11 represent a further 
molecular detail how hypothalamic inflammation may trigger 
leptin resistance and obesity in the very early days of high caloric 
intake (Figure 7).
Our RNF11 expression studies were performed with complete 
hypothalami, including many different cell types (3). It would be 
of interest to observe whether significant RNF11 upregulation 
can be specifically found at the ARC and PVN neurons after 
3 days of HFD.
Furthermore, hypothalamic expression and activity of RNF11 
may potentially be regulated in a time-dependent manner. 
Constant RNF11 upregulation would block NFκB signaling and 
MC3/4R or receptor resensitization, which may be of pathophysi-
ological relevance.
In summary, RNF11 was presented as a new molecular link 
of how HFD exposure may result in functional melanocortin 
dysfunction. RNF11, which was observed to be marginally 
upregulated within the first 3  days of HFD feeding, inhibited 
MC3/4R function in in vitro studies. This lead to the hypothesis; 
that reduction of hypothalamic MC4R signaling, shortly after ini-
tiation of a HFD, may explain the early onset of functional leptin 
resistance, which contributes, in part, to further manifestations 
of obesity (Figure 7).
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